No abstract available
Keywords:
COVID‐19; infliximab; pharmacokinetics.
Publication types
-
Letter
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Antibodies, Monoclonal
-
Antirheumatic Agents*
-
COVID-19*
-
Humans
-
Infliximab
-
Treatment Outcome
Substances
-
Infliximab
-
Antibodies, Monoclonal
-
Antirheumatic Agents